Epiconone, one novel cyclohexenone from endophytic fungi Epicoccum sp. 1-042.

J Antibiot (Tokyo)

CAMS Key Laboratory of Synthetic Biology for Drug Innovation, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, People's Republic of China.

Published: March 2025

Targeting drug-resistant Acinetobacter baumannii, two fungal strains, Epicoccum sp. 1-042 and Penicillium sp. 19-115, were identified from 35 fungi isolated from Tibet. Bioassay-guided isolation from Epicoccum sp. 1-042 yielded a novel cyclohexenone, epiconone (1), and parasitenone (2), while patulin (3) was isolated from Penicillium sp. 19-115. Structural elucidation was accomplished through comprehensive spectroscopic analysis and quantum chemistry calculations. The biosynthetic pathways of compounds 1 and 2 were proposed based on bioinformatics analysis. Compounds 1 - 3 exhibited antibacterial activity against carbapenem-resistant Acinetobacter baumannii (CRAB) with MIC values ranging from 4 to 128 μg mL.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41429-025-00813-yDOI Listing

Publication Analysis

Top Keywords

epicoccum 1-042
12
novel cyclohexenone
8
acinetobacter baumannii
8
penicillium 19-115
8
epiconone novel
4
cyclohexenone endophytic
4
endophytic fungi
4
fungi epicoccum
4
1-042 targeting
4
targeting drug-resistant
4

Similar Publications

Epiconone, one novel cyclohexenone from endophytic fungi Epicoccum sp. 1-042.

J Antibiot (Tokyo)

March 2025

CAMS Key Laboratory of Synthetic Biology for Drug Innovation, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, People's Republic of China.

Targeting drug-resistant Acinetobacter baumannii, two fungal strains, Epicoccum sp. 1-042 and Penicillium sp. 19-115, were identified from 35 fungi isolated from Tibet.

View Article and Find Full Text PDF

Bioactivity-Based Molecular Networking-Guided Isolation of Epicolidines A-C from the Endophytic Fungus sp. 1-042.

J Nat Prod

June 2024

CAMS Key Laboratory of Synthetic Biology for Drug Innovation, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tiantan xili No. 1, Beijing 100050, People's Republic of China.

Article Synopsis
  • Researchers discovered three new compounds, epicolidines A-C, and one known compound, PF 1052, from an endophytic fungus in Tibet, utilizing bioactivity-based molecular networking-guided fractionation.
  • The chemical structures of these compounds were determined through methods like spectroscopy, hydrolysis, quantum chemistry calculations, and X-ray diffraction.
  • Notably, one compound showed strong antibacterial activity against vancomycin-resistant enterococci (VRE), with a minimum inhibitory concentration (MIC) of 0.25 μg/mL, outperforming a common antibiotic combination and achieving a 100% survival rate in a VRE infection model.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!